Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride effects on emotional processing
NCT03572790Completed
- Sponsor
- University of Oxford
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Prucalopride with Placebo (2 arms). Primary endpoints: Recognition of positive and negative facial expressions at Day 7 and Performance on Auditory Verbal Learning Task (AVLT) at Day 7. Started Jun 2018; status: completed.
02
Drugs
prucalopride
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03572790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03572790.